Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;27(1):101246.
doi: 10.1016/j.gim.2024.101246. Epub 2024 Nov 21.

Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive risk

Collaborators, Affiliations

Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive risk

Jacquelyn Powers et al. Genet Med. 2025 Jan.

Abstract

Purpose: Pathogenic germline variants (PGVs) in a subset of cancer predisposition genes (CPGs) are associated with adult-onset autosomal dominant (AD) cancer susceptibility and life-limiting autosomal recessive (AR) disease. Counseling in adult cancer genetics clinics regarding reproductive risk for PGV heterozygotes is limited.

Methods: Estimated heterozygote frequencies across ancestries were calculated for AD CPGs with AR risk (ATM, BRCA1, BRCA2, BRIP1, FH, NBN, MLH1, MSH2, MSH6, PMS2, RAD51C, SDHA, SDHB, and SDHD) from gnomADv.3.0, the Penn Medicine Biobank, and FLOSSIES.

Results: Average frequencies of heterozygotes with PGVs across ancestries for BRCA1 and BRCA2 were 0.33% ± 0.41% and 0.43% ± 0.36%, with variability cross-ancestry from 0.06% to 1.32% and 0.17% to 1.29%, respectively. ATM had the next highest PGV heterozygote frequency (0.31% ± 0.12%) and SDHD the lowest (0.01% ± 0.01%) average PGV heterozygote frequency. Heterozygote PGV frequencies from gnomAD were similar as cancer-free individuals in Penn Medicine Biobank and higher than in the FLOSSIES data.

Discussion: Heterozygote frequency estimates for AD CPGs that cause AR disease provides information to facilitate discussions regarding reproductive risk. Future studies are needed to assess whether utilization of these data will influence couples' reproductive risk planning.

Keywords: Autosomal dominant cancer susceptibility; Autosomal recessive conditions; Genetic counseling; Heterozygote frequency; Reproductive counseling.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare no conflicts of interest.

References

    1. Rahman N. Realizing the promise of cancer predisposition genes. Nature 505, 302–8 (2014). - PMC - PubMed
    1. Gregg AR & Edwards JG Prenatal genetic carrier screening in the genomic age. Semin Perinatol 42, 303–306 (2018). - PubMed
    1. Mets S, Tryon R, Veach PM & Zierhut HA Genetic Counselors’ Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels. J Genet Couns 25, 359–372 (2016). - PubMed
    1. Reumkens K. et al. Reproductive Decision Support: Preferences and Needs of Couples at Risk for Hereditary Cancer and Clinical Geneticists. J Genet Couns 27, 920–926 (2018). - PMC - PubMed
    1. Daly MB et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw 21, 1000–1010 (2023). - PubMed

LinkOut - more resources